Biofarma | The Leading Vaccine Manufacturer in Indonesia

News & Event

Thursday, 3 September 2026

Bio-RV, a Neonatal Rotavirus Vaccine Developed Through Bio Farma–MCRI Collaboration, Receives Marketing Authorization from the Indonesian Food and Drug Authority, BPOM

Bio Farma and MCRI mark a milestone with NIE approval for Bio-RV, strengthening child protection against rotavirus.

Tuesday, 9 December 2025

Bio Farma Receives Official Visit from the Governor of Victoria to Strengthen Strategic Cooperation in Health and Biotechnology

PT Bio Farma (Persero) received the official visit of the Governor of the State of Victoria, Australia, Margaret Gardner, accompanied by the Victorian Government delegation, at its Headquarters in Bandung.

Wednesday, 5 November 2025

26th DCVMN AGM Successfully Held: Bio Farma and DCVMN Strengthen Global Collaboration to Build a Resilient and Inclusive Vaccine Ecosystem

PT Bio Farma (Persero), the parent company of the state-owned pharmaceutical holding, successfully co-hosted the 26th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers Network (DCVMN) 2025, held from October 29 to 31, 202...

Thursday, 30 October 2025

Strengthening Global Collaboration to Build a Resilient and Sustainable Vaccine Ecosystem

The 26th Developing Countries Vaccine Manufacturers Network (DCVMN) Annual General Meeting (AGM) officially opened today. Held at The Meru, Sanur, Bali, from October 29 to 31, 2025, the prestigious forum is co-hosted by PT Bio Farma (Persero).